MiRagen Therapeutics Inc. plans to raise up to $50 million in an at-the-market issuance of common stock, with Cowen and Co. LLC acting as the sales agent.
MiRagen to raise $50M via common stock issuance
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective